Canada: Intellectual Property

On June 8, 2012, Genentech’s lawsuit seeking a declaration that US Patent No. 6,733,752 was invalid and not-infringed by Genentech’s trastuzumab product (HERCEPTIN).

Health Canada specifically contemplates certain proteins as SEBs in its Guidance, although Health Canada has not limited SEBs to only particular classes of drugs.

On May 23, 2012, the Federal Court held that Merck Frosst Canada Ltd. ("Merck") is liable to Apotex Inc. ("Apotex") for damages under section 8 of the Patented Medicines (Notice of Compliance) Regulations (the "Regulations"), but exercised its discretion to reduce the amount of compensation payable based on a defence of ex turpi causa.

For World IP Day 2025, we connected with members of our Trademarks & Copyright team for a short interview, reflecting on this year's theme from the World Intellectual Property Organization...

The implied undertaking rule prohibits litigants from using information obtained through the discovery process for any purpose other than the proceeding in which the information was disclosed.

AI has revolutionized the entertainment and gaming industry and has a multitude of uses.

For World IP Day 2025, we connected with members of our Trademarks & Copyright team for a short interview, reflecting on this year's theme from the World Intellectual Property Organization...

There's a new comeback story in town, and it's about as dramatic as a Snyder Cut reveal. Mattel has successfully clawed back the lucrative rights to make DC-themed action...

You may be interested in intellectual property (IP) license agreements if you're a creator or business looking to monetize your work or if you're seeking to utilize someone else's intellectual property.

On February 26, 2025, the Patent Appel Board was scheduled to hear submissions whether Canadian Patent Application No. 3,137,161 can comply with the formalities of the Patent Act and Rules.

On July 17, 2024, the Canadian Intellectual Property Office (CIPO) launched a new electronic system and portal, MyCIPO Patents, as part of its Next Generation Patents initiative.

In October 2019, amendments to the Patent Act (R.S.C., 1985, c. P-4) were made introducing the Due Care standard in order to satisfy Canada's obligations under the Patent Law Treaty...